Karolinska Development cancer news

Karolinska formed subsidiary KDev Oncology AB to focus on cancer. The subsidiary will hold projects from portfolio companies Akinion Pharmaceuticals AB (Solna, Sweden) and GliGene AB (Stockholm, Sweden). Karolinska said Carl Harald Janson, a director at Karolinska portfolio companies Alexar AB (Stockholm, Sweden), Oncopeptides AB (Stockholm, Sweden), Clanotech AB (Stockholm, Sweden) and Akinion, will be CEO of the newco. ...